Mission statement · Company scope
“Our mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function to enable patients with these disorders to live fuller and healthier lives.”
In use2026 – now1 sighting
First seenApr 2026Added
Last seenApr 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Customer-centric · Impact
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 28 words · reading grade 16.5
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_2fa62347f53fa0c2
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-04-23 · sec_sentence · 20-F · accession 0001104659-26-047872
View filing ↗0 to compareCompare